Rectal Cancer - Clinical Trial (09-003)
RTOG 0822: A Phase II Evaluation of Preoperative Chemoradiotherapy Utilizing Intensely Modulated Radiation Therapy (MRT) in Combination with Capecitabine and Oxaliplatin for Patients with Locally Advanced Rectal Cancer
Protocol ID
Protocol Description
It is possible to reduce the amount of radiation delivered to the normal tissues that surround cancer by using an advanced radiation therapy delivery technique called intensity-modulated radiation therapy (IMRT). The purpose of this study is to determine whether reducing the amount of radiation, given along with chemotherapy, to these normal tissues will reduce the side effects associated with standard radiation and chemotherapy treatment for rectal cancer. The chemotherapy used in this study are commonly given for rectal cancer. The research part of this study is looking at the use of IMRT with the chemotherapy.
Eligibility Criteria
Patients with rectal cancer
Primary Investigator(s)
- Beatrice Bloom, MD